🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the producers of acetaminophen, alleging the corporations withheld potential risks that the medication presented to children's neurological development.

This legal action arrives a month after Former President Trump promoted an unsubstantiated connection between consuming Tylenol - referred to as paracetamol - while pregnant and autism spectrum disorder in offspring.

The attorney general is taking legal action against J&J, which once produced the medication, the only pain reliever recommended for women during pregnancy, and the current manufacturer, which currently produces it.

In a official comment, he said they "deceived the public by gaining financially from suffering and pushing pills without regard for the potential hazards."

The manufacturer states there is lacking scientific proof connecting Tylenol to autism spectrum disorder.

"These manufacturers misled for generations, deliberately risking numerous people to increase profits," the attorney general, a Republican, declared.

The company said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the safety of acetaminophen and the potential impact that could have on the health of US mothers and children."

On its online platform, the company also said it had "continuously evaluated the applicable studies and there is lacking reliable evidence that demonstrates a proven link between using paracetamol and autism spectrum disorder."

Associations acting on behalf of physicians and health professionals concur.

The leading OB-GYN organization has declared paracetamol - the primary component in acetaminophen - is among limited choices for pregnant women to address pain and fever, which can pose significant medical dangers if left untreated.

"In more than two decades of investigation on the utilization of paracetamol in pregnancy, no reliable research has successfully concluded that the usage of acetaminophen in any stage of pregnancy causes neurological conditions in children," the association said.

The lawsuit references current declarations from the Trump administration in claiming the medication is potentially dangerous.

In recent weeks, Trump raised alarms from medical authorities when he instructed pregnant women to "resist strongly" not to take Tylenol when unwell.

Federal regulators then released a statement that medical professionals should think about restricting the usage of acetaminophen, while also mentioning that "a proven link" between the medication and autism spectrum disorder in young ones has not been established.

Health Secretary Robert F Kennedy Jr, who oversees the FDA, had pledged in April to conduct "extensive scientific investigation" that would determine the source of autism spectrum disorder in a short period.

But experts cautioned that discovering a unique factor of autism spectrum disorder - believed by scientists to be the consequence of a intricate combination of inherited and surrounding conditions - would not be simple.

Autism spectrum disorder is a form of lifelong neurodivergence and condition that affects how persons perceive and relate to the environment, and is identified using doctors' observations.

In his court filing, Paxton - aligned with the former president who is campaigning for the Senate - asserts Kenvue and J&J "intentionally overlooked and sought to suppress the evidence" around acetaminophen and autism spectrum disorder.

This legal action aims to force the corporations "remove any promotional materials" that asserts Tylenol is reliable for pregnant women.

The court case mirrors the concerns of a assembly of guardians of young ones with autism and ADHD who filed suit against the makers of Tylenol in recently.

A federal judge dismissed the lawsuit, saying research from the family's specialists was inconclusive.